Thomas Friedrich Schulz

26PUBLICATIONS
110CO-AUTHORS
Molecular targetsInnate immunityMedical molecular engineering of nucleic acids and proteinsEpigenetics (incl. genome methylation and epigenomics)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Nov 18, 2025
Toward Anti-Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen.

Aylin Berwanger, Saskia Catherina Stein, Sarah Brandner

|Jul 31, 2025
A critical residue in a conserved RBD epitope determines neutralization breadth of pan-sarbecovirus antibodies with recurring YYDRxxG motifs.

Saskia C Stein, George Ssebyatika, Tim Benecke

|Nov 04, 2024
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.

Saskia C Stein, Guido Hansen, George Ssebyatika

|May 07, 2024
A comprehensive genetic map of cytokine responses in Lyme borreliosis.

Javier Botey-Bataller, Hedwig D Vrijmoeth, Jeanine Ursinus

|Mar 13, 2024
Correction for Gupta et al., "Bromo- and Extraterminal Domain Chromatin Regulators Serve as Cofactors for Murine Leukemia Virus Integration".

Saumya Shree Gupta, Tobias Maetzig, Goedele N Maertens

|Feb 08, 2024
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor.

Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak

Pageof 5

Frequent Collaborators

5 joint publications

Thomas Krey

4 joint publications

Thomas Pietschmann

2 joint publications

Sandra Koch

2 joint publications

Gisa Gerold